Biocon & Tabuk Partner for Diabetes Treatment in Middle East
September 26, 2024 17:29
Biocon inks licensing and supply agreement with Tabuk Pharmaceuticals for commercializing its 'GLP-1' products for diabetes and weight management in the Middle East.